Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Edward J. Gorak"'
Autor:
Rami S. Komrokji, Edward J. Gorak, Amy E. DeZern, Wael Saber, Jane Jijun Liu, Steven D. Gore, Christine Borchert, Steffanie H. Wilson, Eric Padron, Donnie Hebert, Jason B. Thompson, Nancy K. Gillis, Nancy L. DiFronzo, Mikkael A. Sekeres, Cecilia Lee, Mary E. Walker, Tareq Al Baghdadi
Publikováno v:
Blood
Introduction: The NHLBI MDS Natural History Study (NCT02775383) is an ongoing prospective cohort study conducted across 144 sites in the U.S. and Israel intended to establish a data and biospecimen repository to advance the understanding of MDS. In r
Autor:
Steven D. Gore, Eric Padron, Amy E. DeZern, Donnie Hebert, James M. Foran, Steven H. Kroft, Myron A. Waclawiw, Alexandra M. Harrington, Jane Jijun Liu, Wael Saber, Steffanie H. Wilson, Jason Walker, Tareq Al Baghdadi, Daniel T. Starczynowski, Johannes B. Goll, Edward J. Gorak, Ling Zhang, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, H. Joachim Deeg, Rafael Bejar, Nancy L. DiFronzo, R. Coleman Lindsley, Rami S. Komrokji, Robert S. Fulton, Harrison Reed, Benjamin L. Ebert, Travis L. Jensen, Gregory A. Abel, Matthew J. Walter
Publikováno v:
Blood. 136:32-33
Introduction: The NHLBI National MDS Study (NCT02775383) is a prospective cohort study conducted at 92 community hospitals and 29 academic centers. It enrolls patients undergoing work up for suspected MDS to understand the genetic, epigenetic, and bi
Autor:
Donald M. Stablein, Amy E. DeZern, Rami S. Komrokji, Myron A. Waclawiw, Steven D. Gore, Gregory A. Abel, Pearlie K. Epling-Burnette, James M. Foran, Edward J. Gorak, Dana E. Rollison, H. Joachim Deeg, Jesse D. Troy, Matthew J. Walter, Lynn C. Moscinski, James R. Cerhan, Daniel T. Starczynowski, Tareq Al Baghdadi, John W. Thomas, Jane Jijun Liu, Mikkael A. Sekeres, Rafael Bejar, Nancy L. DiFronzo
Publikováno v:
Leukemialymphoma. 60(13)
Myelodysplastic syndromes (MDS), a spectrum of heterogeneous hematopoietic stem cell diseases, vary in clinical severity, response to therapy, and propensity toward progression to acute myeloid leukemia. These are acquired clonal disorders resulting
Autor:
Johannes B. Goll, Jaroslaw P. Maciejewski, Wael Saber, William F. Hooper, Robert S. Fulton, Gregory A. Abel, Eric Padron, Edward J. Gorak, Jason Walker, H. Joachim Deeg, Rafael Bejar, Nancy L. DiFronzo, Jane Jijun Liu, R. Coleman Lindsley, Rami S. Komrokji, Mikkael A. Sekeres, Matthew J. Walter, Pearlie K. Epling-Burnette, James M. Foran, Steven D. Gore, Daniel T. Starczynowski, Benjamin L. Ebert, Tareq Al Baghdadi, Amy E. DeZern, Myron A. Waclawiw, Ling Zhang
Publikováno v:
Blood. 134:4271-4271
Introduction: Myelodysplastic syndromes (MDS) are a heterogenous group of blood disorders defined by peripheral cytopenia(s), bone marrow failure, morphological dysplasia, and risk of progression. To understand the genetic, epigenetic and biological
Autor:
Youram Nassir, Stephen J. Noga, Ori Yellin, Debra Mayo, James R. Berenson, Donald S. Gravenor, Regina A. Swift, Edward J. Gorak, Dipti Patel-Donnelly, Robert S. Siegel, Ralph V. Boccia, Tarun Kewalramani, Alberto Bessudo
Publikováno v:
British Journal of Haematology. 160:321-330
Bendamustine, active in multiple myeloma (MM), is a bifunctional mechlorethamine derivative with alkylating properties. Bortezomib, approved to treat MM, is effective in combination with alkylators. The tolerability and efficacy of bendamustine plus
Autor:
Amy E. DeZern, Alexandra M. Harrington, Matthew J. Walter, Pearlie K. Epling-Burnette, Mikkael A. Sekeres, Rami S. Komrokji, Steven D. Gore, Edward J. Gorak, Gregory A. Abel, Tareq Al Baghdadi, Lynn C. Moscinski, Rafael Bejar, Ling Zhang, Steven H. Kroft, Jane Jijun Liu, Donald M. Stablein, Bart L. Scott
Publikováno v:
Blood. 132:4370-4370
Background Myelodysplastic syndromes (MDS) are a collection of hematopoietic disorders with widely variable prognoses and treatment options. Pathologic diagnosis can be challenging and misdiagnosis can impact patient therapy and outcome. How commonly
Autor:
Suezanne E. Parker, Yupin Charoenvit, Jon Norman, Judith E. Epstein, John Nerges, Ruobing Wang, Lucy M. L. Goh, Sanjai Kumar, Richard Stout, Stephen L. Hoffman, Jennifer Ng, Edward J. Gorak, Richard C. Hedstrom, Nicole Freydberg, Esteban Abot, Fernando Trespalacios, Thomas L. Richie, Oluwatoyin Osinowo, Victoria Fallarme-Majam, Erin L. Stoltz
Publikováno v:
Human Gene Therapy. 13:1551-1560
Introduction of a new vaccine requires choosing a delivery system that provides safe administration and the desired level of immunogenicity. The safety, tolerability, and immunogenicity of three monthly 2.5-mg doses of a PfCSP DNA vaccine were evalua
Autor:
Ruobing Wang, Judith Epstein, Fe Maria Baraceros, Edward J. Gorak, Yupin Charoenvit, Daniel J. Carucci, Richard C. Hedstrom, Nancy Rahardjo, Tanya Gay, Peter Hobart, Rick Stout, Trevor R. Jones, Thomas L. Richie, Suezanne E. Parker, Denise L. Doolan, Jon Norman, Stephen L. Hoffman
Publikováno v:
Proceedings of the National Academy of Sciences. 98:10817-10822
We assessed immunogenicity of a malaria DNA vaccine administered by needle i.m. or needleless jet injection [i.m. or i.m./intradermally (i.d.)] in 14 volunteers. Antigen-specific IFN-γ responses were detected by enzyme-linked immunospot (ELISPOT) as
Publikováno v:
The oncologist. 18(12)
UNLABELLED Patients with type 2 diabetes have increased cancer risk and cancer-related mortality, which can be reduced by metformin treatment. However, it is unclear whether metformin can also modulate clinical outcomes in patients with cancer and co
Autor:
David W. Hosmer, James E. Dalen, Jorge L. Yarzebski, Joseph S. Alpert, Joel M. Gore, Robert J. Goldberg, Edward J. Gorak, Priscilla Dalen
Publikováno v:
Circulation. 87:1947-1953
BACKGROUND The purpose of the study was to examine overall differences and temporal trends therein between men and women regarding the incidence rates, in-hospital and long-term survival after initial acute myocardial infarction (AMI), and out-of-hos